H.R. 8366: Pharmacists Ethical Autonomy and Religious Liberties Act

This bill, known as the Pharmacists Ethical Autonomy and Religious Liberties Act (PEARL Act), aims to protect pharmacists' rights to refuse to dispense or sell certain drugs based on their religious beliefs. Specifically, it addresses situations involving the abortion-inducing drugs mifepristone and misoprostol.

Key Provisions

1. Protection from Requirement: Pharmacists, whether employed by private businesses or government agencies, would not be required to dispense or sell mifepristone or misoprostol if doing so conflicts with their sincerely held religious beliefs. This means they cannot face punishment, such as losing their license to practice pharmacy or have funding withdrawn, for choosing not to provide these medications.
2. Civil Action Rights: If a pharmacist is forced to dispense these drugs or faces consequences for refusing, they would have the right to bring a civil lawsuit in a federal district court. This would allow them to seek an injunction against the entity imposing such a requirement or penalty.
3. Definition of Pharmacist: The bill defines "pharmacist" as any individual who is licensed by a state to practice pharmacy, which includes dispensing and selling prescription medications.

Impact on Pharmacists

The bill is intended to ensure that pharmacists can practice their profession while adhering to their personal beliefs without facing legal repercussions or professional penalties. It emphasizes the importance of ethical and religious considerations in the pharmacy practice.

Relevant Companies

None found